Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$10.05 - $12.02 $0 - $0
0 New
0 $0
Q1 2024

Apr 24, 2024

SELL
$11.27 - $13.53 $1,431 - $1,718
-127 Closed
0 $0
Q4 2023

Jan 19, 2024

BUY
$8.77 - $10.85 $8 - $10
1 Added 0.79%
127 $1,000
Q3 2023

Oct 10, 2023

BUY
$9.59 - $11.35 $1,208 - $1,430
126 New
126 $1,000
Q3 2022

Oct 13, 2022

BUY
$8.48 - $11.13 $84,333 - $110,687
9,945 New
9,945 $101,000
Q4 2021

Jan 13, 2022

SELL
$12.09 - $14.68 $1,136 - $1,379
-94 Closed
0 $0
Q3 2021

Oct 12, 2021

SELL
$13.25 - $15.13 $1,060 - $1,210
-80 Reduced 45.98%
94 $1,000
Q2 2021

Sep 20, 2021

SELL
$12.97 - $16.15 $77 - $96
-6 Reduced 3.33%
174 $2,000
Q1 2021

Sep 20, 2021

BUY
$13.59 - $18.54 $2,446 - $3,337
180 New
180 $3,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Activest Wealth Management Portfolio

Follow Activest Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Activest Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Activest Wealth Management with notifications on news.